Company Filing History:
Years Active: 1999
Title: The Innovative Contributions of Andreas Jessel
Introduction
Andreas Jessel is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of severe medical conditions. His work has the potential to impact the lives of many patients suffering from critical illnesses.
Latest Patents
Andreas Jessel holds a patent for the "Use of C1-inactivation for therapy of certain diseases." This patent describes the use of a C1-inactivator for the production of a pharmaceutical aimed at the prophylaxis and treatment of capillary leak syndrome and circulatory shock. These conditions can arise in severe burns, polytrauma, and during operations involving extracorporeal circulation. The patent also addresses the use of cytokines, endogenous mediators, and growth factors produced by genetic engineering in therapeutic applications.
Career Highlights
Jessel is associated with Behringwerke Aktiengesellschaft, a company known for its advancements in biopharmaceuticals. His work at this institution has allowed him to focus on innovative therapies that address complex medical challenges.
Collaborations
Throughout his career, Andreas Jessel has collaborated with esteemed colleagues, including Bernd Eisele and Ulrich Delvos. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Andreas Jessel's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to improving medical treatments. His work continues to pave the way for advancements in therapeutic options for patients facing severe health challenges.